| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
64,832 |
59,764 |
$4.33M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
43,614 |
36,043 |
$4.08M |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
7,657 |
1,103 |
$2.55M |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
19,735 |
18,477 |
$2.49M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
17,812 |
3,442 |
$1.61M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
17,189 |
13,419 |
$1.37M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
12,118 |
2,498 |
$866K |
| 36415 |
Collection of venous blood by venipuncture |
43,841 |
27,972 |
$857K |
| G0378 |
Hospital observation service, per hour |
21,761 |
6,666 |
$693K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
9,528 |
9,036 |
$688K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,566 |
3,213 |
$676K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,607 |
4,800 |
$593K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
6,153 |
1,438 |
$459K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,312 |
2,955 |
$417K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
4,717 |
3,570 |
$278K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,062 |
2,933 |
$271K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
31,772 |
20,348 |
$208K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,056 |
1,801 |
$206K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
1,146 |
541 |
$198K |
| 81003 |
|
16,944 |
15,179 |
$197K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,785 |
3,460 |
$183K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,196 |
1,072 |
$168K |
| 87081 |
|
10,790 |
10,374 |
$150K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,520 |
3,752 |
$143K |
| 80053 |
Comprehensive metabolic panel |
19,558 |
15,966 |
$141K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,578 |
1,503 |
$112K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
5,317 |
3,084 |
$105K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,506 |
1,215 |
$104K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
4,015 |
3,662 |
$104K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,526 |
1,425 |
$103K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,755 |
2,567 |
$81K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,445 |
2,988 |
$77K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,822 |
3,568 |
$76K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,351 |
5,059 |
$75K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
5,722 |
4,335 |
$74K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,521 |
6,356 |
$71K |
| 59025 |
Fetal non-stress test |
778 |
589 |
$66K |
| 71046 |
Radiologic examination, chest; 2 views |
11,061 |
10,330 |
$66K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
3,892 |
3,145 |
$62K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
569 |
500 |
$60K |
| 81025 |
|
9,237 |
8,431 |
$57K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,663 |
2,810 |
$52K |
| 76801 |
|
3,200 |
2,761 |
$52K |
| 97162 |
|
801 |
688 |
$50K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,369 |
3,008 |
$50K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,802 |
1,692 |
$44K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,278 |
2,974 |
$43K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
14,091 |
12,902 |
$43K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
567 |
261 |
$43K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,313 |
841 |
$43K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,829 |
1,600 |
$43K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
407 |
392 |
$40K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
9,229 |
7,417 |
$36K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,131 |
3,550 |
$35K |
| 92650 |
|
806 |
720 |
$34K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
356 |
254 |
$33K |
| 73610 |
|
994 |
916 |
$30K |
| 71045 |
Radiologic examination, chest; single view |
9,907 |
8,700 |
$29K |
| 85027 |
|
11,821 |
7,925 |
$29K |
| 12011 |
|
592 |
564 |
$26K |
| 74018 |
|
2,901 |
2,771 |
$26K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
44,260 |
31,943 |
$26K |
| 73630 |
|
1,174 |
1,076 |
$26K |
| 12001 |
|
473 |
441 |
$26K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
13,936 |
12,003 |
$24K |
| 73130 |
|
957 |
883 |
$23K |
| 87070 |
|
1,411 |
1,286 |
$23K |
| 87486 |
|
1,130 |
1,085 |
$23K |
| 87420 |
|
675 |
668 |
$22K |
| 87077 |
|
5,259 |
4,788 |
$22K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14,466 |
13,961 |
$20K |
| 81001 |
|
16,941 |
15,105 |
$19K |
| 87045 |
|
1,262 |
1,213 |
$19K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
14,796 |
11,837 |
$17K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
224 |
201 |
$16K |
| 85610 |
|
16,592 |
13,298 |
$15K |
| 73110 |
|
582 |
534 |
$15K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,554 |
1,376 |
$14K |
| P9021 |
Red blood cells, each unit |
230 |
144 |
$14K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,664 |
3,068 |
$13K |
| J1644 |
Injection, heparin sodium, per 1000 units |
3,678 |
1,848 |
$13K |
| 82270 |
|
454 |
420 |
$13K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
4,963 |
4,701 |
$12K |
| 73030 |
|
747 |
658 |
$12K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
589 |
455 |
$11K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
50 |
42 |
$11K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
10,676 |
8,297 |
$10K |
| 72131 |
|
152 |
126 |
$10K |
| 83735 |
|
13,059 |
8,808 |
$10K |
| 84702 |
|
3,892 |
3,198 |
$10K |
| 76821 |
|
1,906 |
1,051 |
$9K |
| 83880 |
|
5,524 |
4,577 |
$9K |
| 73090 |
|
452 |
415 |
$9K |
| 84484 |
|
12,204 |
8,846 |
$9K |
| 86900 |
|
4,949 |
4,219 |
$9K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
332 |
125 |
$9K |
| 85730 |
|
14,494 |
12,096 |
$8K |
| 36430 |
|
242 |
155 |
$8K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,209 |
1,910 |
$8K |
| 93971 |
|
488 |
442 |
$8K |
| 76825 |
|
130 |
115 |
$8K |
| 80076 |
|
9,000 |
7,704 |
$8K |
| 76820 |
|
1,329 |
707 |
$8K |
| 73560 |
|
571 |
482 |
$8K |
| 93017 |
|
354 |
316 |
$7K |
| 96376 |
|
2,303 |
1,388 |
$7K |
| 74019 |
|
1,549 |
1,491 |
$7K |
| 76818 |
|
233 |
182 |
$7K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,339 |
1,040 |
$7K |
| 86850 |
|
3,458 |
2,908 |
$6K |
| 70486 |
|
55 |
48 |
$6K |
| 74022 |
|
1,291 |
1,253 |
$5K |
| 87040 |
|
4,363 |
3,661 |
$4K |
| 88304 |
|
462 |
424 |
$4K |
| 82550 |
|
5,427 |
4,552 |
$4K |
| J1756 |
Injection, iron sucrose, 1 mg |
359 |
141 |
$4K |
| 80061 |
Lipid panel |
2,634 |
2,220 |
$4K |
| 82553 |
|
4,208 |
3,603 |
$4K |
| 86901 |
|
4,579 |
3,910 |
$4K |
| 83605 |
|
3,587 |
2,897 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,943 |
3,339 |
$3K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
155 |
126 |
$3K |
| 83690 |
|
12,281 |
10,699 |
$3K |
| J1815 |
Injection, insulin, per 5 units |
1,945 |
830 |
$3K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
208 |
195 |
$3K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
13 |
12 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,218 |
2,807 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,971 |
1,642 |
$3K |
| J7050 |
Infusion, normal saline solution, 250 cc |
3,012 |
1,552 |
$3K |
| 85007 |
|
3,299 |
2,538 |
$3K |
| 73590 |
|
192 |
170 |
$3K |
| 76830 |
Ultrasound, transvaginal |
410 |
375 |
$3K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
208 |
168 |
$2K |
| 29125 |
|
479 |
451 |
$2K |
| 86140 |
|
5,958 |
5,209 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
120 |
99 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,152 |
2,816 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
765 |
636 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
7,429 |
6,738 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,652 |
2,272 |
$2K |
| 73564 |
|
308 |
268 |
$2K |
| 84100 |
|
3,131 |
2,076 |
$2K |
| 96367 |
|
144 |
106 |
$2K |
| 87186 |
|
3,574 |
3,241 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,710 |
5,369 |
$2K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
26 |
24 |
$2K |
| 87210 |
|
1,099 |
1,036 |
$2K |
| 87205 |
|
1,589 |
1,432 |
$2K |
| 73140 |
|
52 |
50 |
$2K |
| 10060 |
|
96 |
84 |
$2K |
| 82565 |
|
288 |
218 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,502 |
1,401 |
$1K |
| 73620 |
|
58 |
53 |
$1K |
| 84112 |
|
60 |
53 |
$1K |
| 85379 |
|
2,539 |
2,187 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,299 |
1,773 |
$1K |
| 97166 |
|
35 |
25 |
$1K |
| 86920 |
|
298 |
232 |
$1K |
| 82947 |
|
2,185 |
919 |
$1K |
| 82330 |
|
426 |
362 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
914 |
874 |
$1K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
157 |
38 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21 |
15 |
$1K |
| 87581 |
|
1,098 |
1,056 |
$967.16 |
| 97161 |
|
14 |
13 |
$964.84 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
83 |
77 |
$839.36 |
| 76775 |
|
58 |
51 |
$816.42 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,413 |
1,321 |
$806.54 |
| 93325 |
|
68 |
65 |
$764.60 |
| 82150 |
|
3,925 |
3,507 |
$752.30 |
| 76770 |
|
29 |
29 |
$749.07 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
1,014 |
607 |
$706.45 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
302 |
262 |
$635.90 |
| J2704 |
Injection, propofol, 10 mg |
592 |
501 |
$607.89 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
810 |
636 |
$579.67 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
620 |
568 |
$576.42 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
14 |
12 |
$554.14 |
| 82962 |
|
83 |
50 |
$549.84 |
| 93970 |
|
72 |
66 |
$519.85 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
26 |
26 |
$519.32 |
| 76827 |
|
131 |
115 |
$490.75 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
327 |
278 |
$490.39 |
| 73502 |
|
155 |
140 |
$486.85 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
851 |
694 |
$483.37 |
| 85652 |
|
2,957 |
2,687 |
$479.58 |
| 82248 |
|
2,373 |
1,984 |
$474.36 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
786 |
575 |
$470.37 |
| 82728 |
|
1,146 |
906 |
$418.37 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
167 |
124 |
$415.62 |
| 84439 |
|
345 |
300 |
$349.08 |
| 83615 |
|
798 |
591 |
$303.75 |
| 85384 |
|
210 |
175 |
$293.29 |
| 86308 |
|
465 |
447 |
$263.61 |
| 84703 |
|
1,468 |
1,350 |
$261.11 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
302 |
134 |
$251.97 |
| 84145 |
|
476 |
361 |
$234.92 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
19 |
14 |
$221.05 |
| C1769 |
Guide wire |
53 |
43 |
$221.05 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
867 |
670 |
$213.01 |
| J2060 |
Injection, lorazepam, 2 mg |
1,149 |
821 |
$213.01 |
| 72100 |
|
62 |
57 |
$209.72 |
| 72110 |
|
12 |
12 |
$205.35 |
| 90715 |
|
367 |
318 |
$203.35 |
| 90714 |
|
125 |
110 |
$202.45 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
2,753 |
2,604 |
$199.88 |
| 83550 |
|
442 |
378 |
$192.46 |
| 87046 |
|
1,016 |
975 |
$183.33 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
61 |
59 |
$181.49 |
| 51701 |
|
1,085 |
1,018 |
$175.19 |
| 88342 |
|
162 |
141 |
$167.57 |
| 82607 |
|
247 |
212 |
$158.28 |
| 87340 |
|
611 |
527 |
$157.53 |
| J3105 |
Injection, terbutaline sulfate, up to 1 mg |
164 |
140 |
$148.35 |
| 84436 |
|
326 |
288 |
$127.23 |
| 82805 |
|
229 |
193 |
$118.37 |
| 93975 |
|
19 |
14 |
$114.27 |
| 82375 |
|
301 |
257 |
$113.67 |
| 83540 |
|
676 |
580 |
$111.03 |
| 83050 |
|
215 |
184 |
$104.27 |
| 87015 |
|
29 |
25 |
$65.43 |
| 83970 |
|
130 |
106 |
$41.60 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,430 |
571 |
$37.95 |
| 73070 |
|
14 |
13 |
$35.85 |
| 87147 |
|
292 |
283 |
$32.10 |
| 84550 |
|
418 |
333 |
$27.62 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
895 |
425 |
$25.43 |
| 84466 |
|
127 |
101 |
$20.25 |
| 85014 |
|
641 |
374 |
$18.55 |
| 84479 |
|
229 |
208 |
$17.21 |
| 84520 |
|
92 |
77 |
$14.04 |
| 84460 |
|
122 |
101 |
$12.56 |
| 84450 |
|
122 |
101 |
$12.56 |
| 84132 |
|
1,117 |
578 |
$12.39 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
12 |
12 |
$11.95 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
343 |
228 |
$9.15 |
| 87427 |
|
1,270 |
1,177 |
$8.74 |
| 82570 |
|
29 |
24 |
$8.06 |
| 85018 |
|
1,017 |
400 |
$7.41 |
| 82803 |
|
111 |
97 |
$3.90 |
| 82746 |
|
64 |
55 |
$3.34 |
| 84295 |
|
209 |
179 |
$3.14 |
| 83930 |
|
29 |
27 |
$2.96 |
| 85045 |
|
93 |
76 |
$1.80 |
| 84156 |
|
31 |
27 |
$1.56 |
| J7510 |
Prednisolone oral, per 5 mg |
85 |
77 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
975 |
619 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
16 |
13 |
$0.00 |
| 87899 |
|
137 |
132 |
$0.00 |
| 88312 |
|
12 |
12 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
69 |
51 |
$0.00 |
| 82140 |
|
53 |
40 |
$0.00 |
| 99152 |
|
13 |
12 |
$0.00 |
| 73080 |
|
32 |
28 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
32 |
28 |
$0.00 |
| 29105 |
|
39 |
37 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
15 |
14 |
$0.00 |
| Q3014 |
Telehealth originating site facility fee |
1,803 |
1,460 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
514 |
356 |
$0.00 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
220 |
98 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
166 |
148 |
$0.00 |
| 94760 |
|
162 |
119 |
$0.00 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
31 |
28 |
$0.00 |
| 12002 |
|
14 |
12 |
$0.00 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
28 |
27 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
123 |
78 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
39 |
36 |
$0.00 |
| C1773 |
Retrieval device, insertable (used to retrieve fractured medical devices) |
35 |
33 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
50 |
41 |
$0.00 |
| 80329 |
|
26 |
25 |
$0.00 |
| 82040 |
|
45 |
31 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
23 |
15 |
$0.00 |
| 72170 |
|
14 |
12 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
50 |
36 |
$0.00 |
| 80069 |
|
124 |
67 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
58 |
39 |
$0.00 |
| 87449 |
|
14 |
12 |
$0.00 |
| 76870 |
|
15 |
12 |
$0.00 |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
36 |
26 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
24 |
12 |
$0.00 |